Toll Brothers Announces New Luxury Home Community Coming Soon to Weddington, North Carolina
WEDDINGTON, N.C., June 12, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today […]
Blink Charging CEO, Brendan Jones, to Present at the J.P. Morgan 2024 Energy, Power & Renewables Conference
Bowie, Md., June 12, 2024 (GLOBE NEWSWIRE) — Blink Charging Co. (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global manufacturer, […]
Jet.AI Announces AI-Powered Jet Card with Empty Leg Benefit
LAS VEGAS, June 12, 2024 (GLOBE NEWSWIRE) — Jet.AI Inc. (“Jet.AI” or the “Company”) (NASDAQ: JTAI), an innovative private aviation […]
TSX News -
High Arctic Announces Executive Appointment and Provides Update on Final Order to Approve Plan of Arrangement
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS […]
Perceptive Capital Solutions Corp Announces Pricing of $75 Million Initial Public Offering
NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) — Perceptive Capital Solutions Corp (the “Company”), a special purpose acquisition company formed […]
FuelPositive: First Scalable Green Ammonia Production System Successfully Installed on Manitoba Farm
SPERLING, Manitoba, June 12, 2024 (GLOBE NEWSWIRE) — FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) (the “Company”) is thrilled to announce […]
Silynxcom Expands Global Reach with New Asian and European Distribution Agreements
Netanya, Israel, June 12, 2024 (GLOBE NEWSWIRE) — Silynxcom Ltd. (NYSE American: SYNX) (“Silynxcom” or the “Company”), a manufacturer and […]
Blue Star Foods Regains Compliance with Nasdaq
Miami, FL, June 12, 2024 (GLOBE NEWSWIRE) — Blue Star Foods Corp., (“Blue Star,” the “Company,” “we,” “our” or “us”) […]
Pineapple Subsidiary SUNation Energy Secures $2.5 Million Project Slated to Directly Benefit Shinnecock Nation
MINNETONKA, Minn., June 12, 2024 (GLOBE NEWSWIRE) — Pineapple Energy Inc. (“Pineapple”), a leading provider of sustainable solar energy and […]
Revive Therapeutics Provides Update on FDA Type C Meeting for Clinical Study of Bucillamine to Treat Long COVID
TORONTO, June 12, 2024 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a […]
